Search Results

There are 11837 results for: content related to: ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma

  1. You have free access to this content
    Chemotherapy only for localized Hodgkin lymphoma

    Journal of Internal Medicine

    Volume 270, Issue 3, September 2011, Pages: 197–205, D. J. Straus

    Version of Record online : 6 JUL 2011, DOI: 10.1111/j.1365-2796.2011.02410.x

  2. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

    Intervention Review

    The Cochrane Library

    Christine Herbst, Fareed Ahmed Rehan, Nicole Skoetz, Julia Bohlius, Corinne Brillant, Holger Schulz, Ina Monsef, Lena Specht and Andreas Engert

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD007110.pub2

  3. Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

    Intervention Review

    The Cochrane Library

    Kathrin Bauer, Nicole Skoetz, Ina Monsef, Andreas Engert and Corinne Brillant

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD007941.pub2

  4. Management and controversies of classical Hodgkin lymphoma in pregnancy

    British Journal of Haematology

    Volume 169, Issue 5, June 2015, Pages: 613–630, Toby A. Eyre, I-Jun Lau, Lucy Mackillop and Graham P. Collins

    Version of Record online : 13 FEB 2015, DOI: 10.1111/bjh.13327

  5. You have free access to this content
    G-CSF is not necessary to maintain over 99% dose–intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis

    British Journal of Haematology

    Volume 137, Issue 6, June 2007, Pages: 545–552, Andrew M. Evens, Jeffrey Cilley, Taylor Ortiz, Mrinal Gounder, Nanjiang Hou, Alfred Rademaker, Sarah Miyata, Kara Catsaros, Connie Augustyniak, Charles L Bennett, Martin S. Tallman, Daina Variakojis, Jane N. Winter and Leo I. Gordon

    Version of Record online : 24 APR 2007, DOI: 10.1111/j.1365-2141.2007.06598.x

  6. You have free access to this content
    Oral Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 100–180,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2227

  7. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly

    British Journal of Haematology

    Volume 170, Issue 2, July 2015, Pages: 179–184, Aspasia Stamatoullas, Pauline Brice, Reda Bouabdallah, Sylvain Mareschal, Vincent Camus, Ilhem Rahal, Patricia Franchi, Hélène Lanic and Hervé Tilly

    Version of Record online : 19 APR 2015, DOI: 10.1111/bjh.13419

  8. You have free access to this content
    A phase II study of dose-dense and dose-intense ABVD (ABVDDD-DI) without consolidation radiotherapy in patients with advanced Hodgkin lymphoma

    British Journal of Haematology

    Volume 166, Issue 1, July 2014, Pages: 118–129, Filippo Russo, Gaetano Corazzelli, Ferdinando Frigeri, Gaetana Capobianco, Luigi Aloj, Francesco Volzone, Annarosaria De Chiara, Annamaria Bonelli, Tindaro Gatani, Gianpaolo Marcacci, Daniela Donnarumma, Cristina Becchimanzi, Elisabetta de Lutio, Franco Ionna, Rosaria De Filippi, Secondo Lastoria and Antonello Pinto

    Version of Record online : 27 MAR 2014, DOI: 10.1111/bjh.12862

  9. You have free access to this content
    Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

    Cancer

    Volume 121, Issue 3, February 1, 2015, Pages: 423–431, Jorge J. Castillo, Mark Bower, Jérémy Brühlmann, Urban Novak, Hansjakob Furrer, Paula Y. Tanaka, Caroline Besson, Silvia Montoto, Kate Cwynarski, Jeremy S. Abramson, Samir Dalia, Michele Bibas, Joseph M. Connors, Michael Furman, Minh-Ly Nguyen, Timothy P. Cooley, Brady E. Beltran, Jaime A. Collins, Julie M. Vose, Blanca Xicoy, Josep-Maria Ribera and for the HIV-Associated Hodgkin Lymphoma in the cART Era Study Group

    Version of Record online : 23 SEP 2014, DOI: 10.1002/cncr.29066

  10. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 416–421, Prahlad Ho, Peter Sherman and Andrew Grigg

    Version of Record online : 27 FEB 2012, DOI: 10.1111/j.1600-0609.2012.01763.x

  11. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood hodgkin disease

    Pediatric Blood & Cancer

    Volume 42, Issue 3, March 2004, Pages: 210–215, H. van den Berg, F. Furstner, C. van den Bos and H. Behrendt

    Version of Record online : 30 OCT 2003, DOI: 10.1002/pbc.10422

  12. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  13. You have free access to this content
    Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation

    Cancer

    Volume 113, Issue 12, 15 December 2008, Pages: 3323–3330, Nina Arakelyan, Christian Berthou, Bernard Desablens, Sophie de Guibert, Vincent Delwail, Marie-Pierre Moles, Philippe Quittet, Jean-Philippe Jais, Pierre Colonna, Jean-Marie Andrieu and and the Groupe Ouest-Est d'Etude des Leucémies et Autres Maladies du Sang

    Version of Record online : 5 NOV 2008, DOI: 10.1002/cncr.23979

  14. You have free access to this content
    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

    British Journal of Haematology

    Volume 152, Issue 5, March 2011, Pages: 551–560, Andrea Gallamini, Caterina Patti, Simonetta Viviani, Andrea Rossi, Francesca Fiore, Francesco Di Raimondo, Maria Cantonetti, Caterina Stelitano, Tatyana Feldman, Paolo Gavarotti, Roberto Sorasio, Antonino Mulè, Monica Leone, Alessandro Rambaldi, Alberto Biggi, Sally Barrington, Federico Fallanca, Umberto Ficola, Stéphane Chauvie, Alessandro Massimo Gianni and for the Gruppo Italiano Terapie Innovative nei Linfomi (GITIL)

    Version of Record online : 20 DEC 2010, DOI: 10.1111/j.1365-2141.2010.08485.x

  15. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  16. Cochrane Clinical Answers

    How does escalated BEACOPP chemotherapy compare with ABVD in people with early unfavorable or advanced stage Hodgkin lymphoma?

    Published Online: 4 AUG 2014, DOI: 10.1002/cca.424
  17. You have free access to this content
    Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation

    British Journal of Haematology

    Volume 118, Issue 1, July 2002, Pages: 189–194, Vincent Delwail, Jean-Philippe Jais, Pierre Colonna and Jean-Marie Andrieu

    Version of Record online : 3 JUL 2002, DOI: 10.1046/j.1365-2141.2002.03564.x

  18. You have free access to this content
    Guidelines for the first line management of classical Hodgkin lymphoma

    British Journal of Haematology

    Volume 166, Issue 1, July 2014, Pages: 34–49, George A. Follows, Kirit M. Ardeshna, Sally F. Barrington, Dominic J. Culligan, Peter J. Hoskin, David Linch, Shalal Sadullah, Michael V. Williams, Jennifer Z. Wimperis and for The British Committee for Standards in Haematology

    Version of Record online : 9 APR 2014, DOI: 10.1111/bjh.12878

  19. Current treatment strategies of the German Hodgkin Study Group (GHSG)

    European Journal of Haematology

    Volume 75, Issue s66, July 2005, Pages: 125–134, Beate Klimm, Volker Diehl, Beate Pfistner and Andreas Engert

    Version of Record online : 6 JUN 2005, DOI: 10.1111/j.1600-0609.2005.00466.x

  20. You have free access to this content
    Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation

    Cancer

    Volume 112, Issue 4, 15 February 2008, Pages: 846–855, Delphine Sénécal, Jean-Philippe Jais, Bernard Desablens, Christian Berthou, Philippe Casassus, Marie-Pierre Moles, Vincent Delwail, Thomas Gastinne, Pierre Colonna and Jean-Marie Andrieu

    Version of Record online : 10 DEC 2007, DOI: 10.1002/cncr.23247